Apremilast Impurity 10 manufacturers
|
| | Apremilast Impurity 10 Basic information |
| Product Name: | Apremilast Impurity 10 | | Synonyms: | Apremilast 2-acetamido impurity;Apremilast Impurity TNA;Apremilast Impurity 5 Sodium Salt;Apremilast impurity 10;Apremilast 2-Acetamido Benzoic Acid Imurity;Apremilast 2-Acetamido Benzoic Acid Sodium Salt Imurity;Benzoic acid, 2-(acetylamino)-6-[[[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]amino]carbonyl]-;Apremilast 2-acetamido benzoic acid | | CAS: | 1809170-71-5 | | MF: | C22H26N2O8S | | MW: | 478.52 | | EINECS: | | | Product Categories: | | | Mol File: | 1809170-71-5.mol |  |
| | Apremilast Impurity 10 Chemical Properties |
| Boiling point | 780.7±60.0 °C(Predicted) | | density | 1.346±0.06 g/cm3(Predicted) | | solubility | DMSO (Sparingly), Methanol (Slightly, Sonicated) | | pka | 2.80±0.36(Predicted) | | form | Solid | | color | White to Light Yellow | | Stability: | Hygroscopic |
| | Apremilast Impurity 10 Usage And Synthesis |
| Uses | 2-(Acetylamino)-6-[[[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]amino]carbonyl]-benzoic Acid is an impurity of Apremilast (A729700), which is an oral phosphodiesterase 4 inhibitor used for treating psoriatic arthritis. |
| | Apremilast Impurity 10 Preparation Products And Raw materials |
|